Literature DB >> 11953976

The influence of patient characteristics, disease variables, and HLA alleles on the development of radiographically evident sacroiliitis in juvenile idiopathic arthritis.

Berit Flatø1, Anna Smerdel, Virginia Johnston, Gunhild Lien, Knut Dale, Odd Vinje, Thore Egeland, Dag Sørskaar, Øystein Førre.   

Abstract

OBJECTIVE: To assess the frequency of sacroiliitis and the radiographic and clinical outcome in juvenile idiopathic arthritis (JIA) and determine patient characteristics, early disease variables, and genetic markers that predict development of sacroiliitis.
METHODS: We performed a retrospective cohort study of 314 (79%) of the 400 JIA patients first admitted to the hospital between 1980 and 1985. The participants were examined after a median disease duration of 14.9 years (range 11.7-25.1). Radiographs of the sacroiliac joints, hips, ankles, and tarsi were obtained and studied in a blinded manner by 2 radiologists. The presence of HLA-DRB1 and DPB1 alleles was determined by genotyping and that of HLA-B27 by serologic testing. Variables relating to the onset and course of the disease were obtained by chart reviews.
RESULTS: Twenty (6%) of the JIA patients developed radiographic sacroiliitis according to the New York criteria. In 9 patients (45%), sacroiliitis had not been demonstrated before the followup examination. At followup, spinal flexion (lateral and anterior) was reduced in 70-75% of patients with sacroiliitis and in 30-35% of those without sacroiliitis. Compared with the JIA patients without sacroiliitis, those with sacroiliitis more frequently had inflammatory back pain, enthesitis, radiographic changes in the hips and calcanei, erosions of any peripheral joint, and uveitis. Predictors of sacroiliitis were HLA-B27, absence of DPB1*02, hip joint involvement within the first 6 months, and disease onset after age 8 years. The following factors were more common among patients in whom sacroiliitis developed than in other JIA patients: DRB1*04, male sex, family history of ankylosing spondylitis, psoriasis, inflammatory back pain, and enthesitis within the first 6 months.
CONCLUSION: In the current study, radiographically evident sacroiliitis had developed in 6% of JIA patients after a median disease duration of 14.9 years. HLA-B27, absence of DPB1*02, late onset of disease, and early hip involvement were predictors of sacroiliitis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11953976     DOI: 10.1002/art.10146

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  22 in total

1.  Cervical involvement in juvenile-onset ankylosing spondylitis with bone scintigraphy.

Authors:  Ersoy Kekilli; Cengiz Yagmur; Omer Murat Aydin
Journal:  Rheumatol Int       Date:  2003-09-20       Impact factor: 2.631

2.  Spontaneous atlantoaxial subluxation as a presenting manifestation of juvenile ankylosing spondylitis in a female HLA-B27-negative patient.

Authors:  Luciana Breda; Carlo Palazzi; Giuseppina de Michele; Sara De Sanctis; Francesco Chiarelli
Journal:  Eur J Pediatr       Date:  2005-03-30       Impact factor: 3.183

3.  M694V mutation may have a role in susceptibility to ankylosing spondylitis.

Authors:  Servet Akar; Merih Birlik; Ismail Sari; Fatos Onen; Nurullah Akkoc
Journal:  Rheumatol Int       Date:  2009-01-17       Impact factor: 2.631

4.  Evaluation and Treatment of Enthesitis-Related Arthritis.

Authors:  Pamela F Weiss
Journal:  Curr Med Lit Rheumatol       Date:  2013

Review 5.  Early axial spondyloarthritis.

Authors:  Robert A Colbert
Journal:  Curr Opin Rheumatol       Date:  2010-09       Impact factor: 5.006

Review 6.  Adult outcomes of childhood-onset rheumatic diseases.

Authors:  Aimee Hersh; Emily von Scheven; Ed Yelin
Journal:  Nat Rev Rheumatol       Date:  2011-04-12       Impact factor: 20.543

7.  Spondyloarthritis in a pediatric population: risk factors for sacroiliitis.

Authors:  Matthew L Stoll; Rafia Bhore; Molly Dempsey-Robertson; Marilynn Punaro
Journal:  J Rheumatol       Date:  2010-08-03       Impact factor: 4.666

8.  Evaluation of factors affecting the duration of disease-modifying anti-rheumatic drugs application in patients with enthesitis-related arthritis.

Authors:  Ayşenur Paç Kısaarslan; Betül Sözeri; Zübeyde Gündüz; Gökmen Zararsız; Hakan Poyrazoğlu; Ruhan Düşünsel
Journal:  Eur J Rheumatol       Date:  2019-04-22

9.  Juvenile ankylosing spondylitis--is it the same disease as adult ankylosing spondylitis?

Authors:  Amita Aggarwal; Pravin Hissaria; Ramnath Misra
Journal:  Rheumatol Int       Date:  2003-12-04       Impact factor: 2.631

Review 10.  Juvenile spondyloarthropathies.

Authors:  R Hal Scofield; Andrea L Sestak
Journal:  Curr Rheumatol Rep       Date:  2012-10       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.